4//SEC Filing
SCHNEIER CRAIG ERIC 4
Accession 0001127602-11-007663
CIK 0000875045other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:53 PM ET
Size
22.8 KB
Accession
0001127602-11-007663
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
SCHNEIER CRAIG ERIC
EVP, HR, Public Affairs & Comm
Transactions
- Exercise/Conversion
Common Stock
2011-02-23+953→ 21,466.279 total - Tax Payment
Common Stock
2011-02-23$66.76/sh−1,295$86,454→ 20,171.279 total - Tax Payment
Common Stock
2011-02-23$66.76/sh−303$20,228→ 19,868.279 total - Sale
Common Stock
2011-02-25$68.20/sh−9,725$663,245→ 19,868.279 total - Exercise/Conversion
Restricted Stock Unit
2011-02-23−953→ 19,428 totalExercise: $0.00Exp: 2014-02-23→ Common Stock (953 underlying) - Exercise/Conversion
Common Stock
2011-02-23+4,077→ 20,513.279 total - Exercise/Conversion
Common Stock
2011-02-25$49.31/sh+9,725$479,540→ 29,593.279 total - Exercise/Conversion
Restricted Stock Unit
2011-02-23−4,077→ 20,381 totalExercise: $0.00Exp: 2014-02-23→ Common Stock (4,077 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2011-02-25−9,725→ 0 totalExercise: $49.31Exp: 2017-02-11→ Common Stock (9,725 underlying) - Other
Restricted Stock Unit
2011-02-23−1,086→ 18,342 totalExercise: $0.00Exp: 2014-02-23→ Common Stock (0 underlying)
Holdings
- 460(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]There is no conversion or exercise price for this stock unit.
- [F3]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- [F4]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
- [F5]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- [F6]The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001226289
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:53 PM ET
- Size
- 22.8 KB